Amer Assal
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
- Hematology 17
- Hematopoietic Stem Cell Transplantation 9
- Acute Myeloid Leukemia Research 5
- Multiple Myeloma Research and Treatments 4
- Oncology 11
- Cancer Treatment and Pharmacology 3
- Cancer Immunotherapy and Biomarkers 3
- CAR-T cell therapy research 3
- Co-authors
- Xingxing Zang (3 shared papers)Kim C. Ohaegbulam (1 shared paper)Yu Yao (1 shared paper)Eszter Lázár‐Molnár (1 shared paper)Markus Y. Mapara (14 shared papers)Murali Janakiram (7 shared papers)Gopichand Pendurti (1 shared paper)Xiaoxin Ren (1 shared paper)
- Journals
- Blood (8 papers)Transplantation and Cellular Therapy (4 papers)Biology of Blood and Marrow Transplantation (4 papers)Frontiers in Immunology (2 papers)Blood Coagulation & Fibrinolysis (2 papers)
- Partner nations
- United StatesSaudi ArabiaUnited Kingdom
In The Last Decade
Amer Assal
30 papers receiving 963 citations
Amer Assal's Hit Papers
Peers
Comparison fields: 5 of 74
- Oncology 507
- Immunology 383
- Hematology 75
- Internal Medicine 13
- Pulmonary and Respiratory Medicine 117
Countries citing papers authored by Amer Assal
This map shows the geographic impact of Amer Assal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amer Assal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amer Assal more than expected).
Fields of papers citing papers by Amer Assal
This network shows the impact of papers produced by Amer Assal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amer Assal. The network helps show where Amer Assal may publish in the future.
Co-authors
The 25 scholars most cited alongside Amer Assal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway Hit paper breakdown → | 2014 | 669 |
| 2 | 2018 | 78 | |
| 3 | 2015 | 40 | |
| 4 | 2016 | 29 | |
| 5 | 2020 | 19 | |
| 6 | 2021 | 16 | |
| 7 | 2017 | 15 | |
| 8 | 2020 | 14 | |
| 9 | 2021 | 13 | |
| 10 | 2019 | 11 | |
| 11 | 2020 | 9 | |
| 12 | 2021 | 7 | |
| 13 | 2021 | 5 | |
| 14 | 2023 | 5 | |
| 15 | 2014 | 5 | |
| 16 | 2016 | 4 | |
| 17 | 2013 | 4 | |
| 18 | 2020 | 4 | |
| 19 | 2025 | 3 | |
| 20 | 2022 | 3 |
About Amer Assal
Amer Assal is a scholar working on Hematology, Oncology, Immunology, Emergency Medicine and Infectious Diseases, having authored 33 papers that have together received 969 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (9 papers), Immune Cell Function and Interaction (7 papers), Acute Myeloid Leukemia Research (5 papers), Immunotherapy and Immune Responses (4 papers), Multiple Myeloma Research and Treatments (4 papers), Cancer Treatment and Pharmacology (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Oncology (507 citations), Immunology (383 citations), Hematology (75 citations), Internal Medicine (13 citations) and Pulmonary and Respiratory Medicine (117 citations). Amer Assal has collaborated with scholars based in United States, Saudi Arabia and United Kingdom. Frequent co-authors include Xingxing Zang, Kim C. Ohaegbulam, Yu Yao, Eszter Lázár‐Molnár, Markus Y. Mapara, Murali Janakiram, Gopichand Pendurti, Xiaoxin Ren, Balázs Halmos and Alain Borczuk. Their work appears in journals such as Blood, Transplantation and Cellular Therapy, Biology of Blood and Marrow Transplantation, Frontiers in Immunology and Blood Coagulation & Fibrinolysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.